Cargando…

Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia

The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbar, Sheikh Mohammad Fazle, Al Mahtab, Mamun, Begum, Ferdousi, Hossain, Shaikh A. Shahed, Sarker, Sukumar, Shrestha, Ananta, Khan, Md. Sakirul Islam, Yoshida, Osamu, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069988/
https://www.ncbi.nlm.nih.gov/pubmed/33921259
http://dx.doi.org/10.3390/vaccines9040374
_version_ 1783683365934727168
author Akbar, Sheikh Mohammad Fazle
Al Mahtab, Mamun
Begum, Ferdousi
Hossain, Shaikh A. Shahed
Sarker, Sukumar
Shrestha, Ananta
Khan, Md. Sakirul Islam
Yoshida, Osamu
Hiasa, Yoichi
author_facet Akbar, Sheikh Mohammad Fazle
Al Mahtab, Mamun
Begum, Ferdousi
Hossain, Shaikh A. Shahed
Sarker, Sukumar
Shrestha, Ananta
Khan, Md. Sakirul Islam
Yoshida, Osamu
Hiasa, Yoichi
author_sort Akbar, Sheikh Mohammad Fazle
collection PubMed
description The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunization (EPI) and vaccinating all infants and children three times within 1 year of birth (HepB3). Recently, the WHO advocate birth-dose hepatitis B vaccination (HepB-BD) as soon as possible after birth, preferably within 24 hours. In 2016, the SEARO endorsed a regional hepatitis B control goal with a target of hepatitis B surface antigen (HBsAg) seroprevalence of ≤1% among children aged ≥5 years by 2020. Of the 11 SEARO countries, four achieved this target on schedule. Out of these four countries, two countries (Bangladesh and Nepal) have not adopted HepB-BD in EPI program. On the other hand, the coverage of HepB3 is not satisfactory in some SEARO countries, including India which adopted HepB-BD but could not achieve the overall target of SEARO. Thus, it is a point of debate whether emphasis should be placed on proper implementation of HepB3 or whether a new agenda of HepB-BD should be incorporated in developing countries of SEARO. The article discusses strengthening and expanding the Hepatitis B vaccination program in SEARO countries with an emphasis on HepB and HepB-BD programs.
format Online
Article
Text
id pubmed-8069988
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80699882021-04-26 Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia Akbar, Sheikh Mohammad Fazle Al Mahtab, Mamun Begum, Ferdousi Hossain, Shaikh A. Shahed Sarker, Sukumar Shrestha, Ananta Khan, Md. Sakirul Islam Yoshida, Osamu Hiasa, Yoichi Vaccines (Basel) Review The World Health Organization (WHO) South-East Asia Regional Office (SEARO) covers 11 countries with a combined population of about 2 billion people, making it the most populous of the six WHO regions. In 1992, the WHO advocated including the hepatitis B vaccine in the Expanded Program of Immunization (EPI) and vaccinating all infants and children three times within 1 year of birth (HepB3). Recently, the WHO advocate birth-dose hepatitis B vaccination (HepB-BD) as soon as possible after birth, preferably within 24 hours. In 2016, the SEARO endorsed a regional hepatitis B control goal with a target of hepatitis B surface antigen (HBsAg) seroprevalence of ≤1% among children aged ≥5 years by 2020. Of the 11 SEARO countries, four achieved this target on schedule. Out of these four countries, two countries (Bangladesh and Nepal) have not adopted HepB-BD in EPI program. On the other hand, the coverage of HepB3 is not satisfactory in some SEARO countries, including India which adopted HepB-BD but could not achieve the overall target of SEARO. Thus, it is a point of debate whether emphasis should be placed on proper implementation of HepB3 or whether a new agenda of HepB-BD should be incorporated in developing countries of SEARO. The article discusses strengthening and expanding the Hepatitis B vaccination program in SEARO countries with an emphasis on HepB and HepB-BD programs. MDPI 2021-04-12 /pmc/articles/PMC8069988/ /pubmed/33921259 http://dx.doi.org/10.3390/vaccines9040374 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Akbar, Sheikh Mohammad Fazle
Al Mahtab, Mamun
Begum, Ferdousi
Hossain, Shaikh A. Shahed
Sarker, Sukumar
Shrestha, Ananta
Khan, Md. Sakirul Islam
Yoshida, Osamu
Hiasa, Yoichi
Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
title Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
title_full Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
title_fullStr Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
title_full_unstemmed Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
title_short Implications of Birth-Dose Vaccination against Hepatitis B Virus in Southeast Asia
title_sort implications of birth-dose vaccination against hepatitis b virus in southeast asia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069988/
https://www.ncbi.nlm.nih.gov/pubmed/33921259
http://dx.doi.org/10.3390/vaccines9040374
work_keys_str_mv AT akbarsheikhmohammadfazle implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT almahtabmamun implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT begumferdousi implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT hossainshaikhashahed implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT sarkersukumar implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT shresthaananta implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT khanmdsakirulislam implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT yoshidaosamu implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia
AT hiasayoichi implicationsofbirthdosevaccinationagainsthepatitisbvirusinsoutheastasia